Objective: To investigate the prevalence of maternal selenium deficiency and its effects on pregnancy outcomes in pregnant women with HIV in Lagos, Nigeria.
| INTRODUCTION
Micronutrient deficiencies, including selenium deficiency, are common during pregnancy, especially among women from economically disadvantaged backgrounds, whose diets tend to be low in minerals and vitamins. 1 These deficiencies are even more widespread in HIV-infected populations and are associated with impaired immune responses, weakened epithelial integrity, and accelerated HIV disease progression.
1,2
Selenium plays an important role in the maintenance of human health. 3 It is a component of several selenoproteins and is required for the activity of glutathione peroxidase, a vital intracellular antioxidant that prevents oxidative cellular damage. 3, 4 Various health problems such as nail and hair loss, gastroenteritis, and dermatitis could be associated with persistent exposure to high levels of selenium, but the most notable health effects are related to a selenium-deficient state. 5 Selenium deficiency has been linked to several pathological conditions, especially in individuals with HIV infections. 4, 5 Consequently, several studies have investigated the role of selenium in the disease progression, morbidity, and mortality of HIV-seropositive individuals. [4] [5] [6] [7] [8] [9] In most of these studies, selenium supplementation improved their survival and slowed the disease progression. 4, [6] [7] [8] Micronutrient deficiencies are particularly prevalent among pregnant women in low-income countries such as Nigeria, and these deficiencies can have detrimental effects on pregnancy outcomes. 1 The demand for selenium during pregnancy is increased to support optimal fetal growth, resulting in decreased maternal blood and tissue concentrations of selenium. 7 However, data on the relationship between selenium status and pregnancy outcomes are conflicting. Moreover, few studies have examined this relationship among black African women with HIV infections.
The present study was designed to investigate the prevalence of a low maternal selenium concentration and its effects on pregnancy outcomes among pregnant women with HIV seen at Lagos University Teaching Hospital, Lagos, Nigeria. 
| MATERIALS AND METHODS
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principles of the Helsinki Declaration were applied throughout the course of the study. All participants were counselled prior to enroll- The primary endpoint was the pregnancy outcome (preterm delivery; term delivery with a low delivery weight). The secondary endpoints were the maternal and the perinatal mortality.
Descriptive statistics for all data were computed using SPSS version 22.0 (IBM, Amonk, NY, USA). Quantitative data were tested for normality with the Kolmogorov-Smirnov test. Associations between continuous variables were tested using the independent sample t test (normal distribution) or the Mann-Whitney U test (skewed data), whereas categorical variables were compared using the χ 2 test or the Fisher exact test, as appropriate. This was followed by multivariate analysis using binary logistic regression models to study the effects of the major baseline characteristics on the pregnancy outcome. P<0.05
was considered statistically significant.
| RESULTS
Initially, 122 patients who were HIV seropositive at 14-26 weeks of singleton pregnancies were enrolled. However, three women withdrew their consent during the course of the study for personal or cultural reasons, four women were lost to follow-up, and two women experienced mid-trimester pregnancy loss. Therefore, the final analysis included 113 women; 23 (20.4%) patients had a selenium concentration below the reference range (<0.89 μmol/L) and 90 (79.6%) with a normal selenium concentration.
Women with a low selenium concentration and those with a normal selenium level did not differ significantly in terms of age, parity, pregnancy duration, occupation, education level, tribe, time since HIV diagnosis, and cumulative duration of ART (Table 1) .
However, women with a low selenium concentration had a significantly lower CD4 + count (P<0.001) and a significantly higher viral load (P=0.017) compared with women with a normal selenium concentration (Table 1) .
Of the 113 participants, 11 (9.7%) had preterm deliveries ( Table 2 ).
The preterm delivery rate was 6.9 times higher among patients with low maternal selenium concentration than those with a normal selenium concentration (P=0.011). Among the 102 term deliveries, 12 (11.8%) patients had neonates with a low delivery weight, and the rate among women with a low selenium concentration 16.1 times higher than among women with a normal selenium concentration (P=0.003). There were 3 (2.7%) maternal deaths and 8 (7.1%) perinatal deaths recorded, and the rate did not differ between patients with low or normal selenium concentrations ( Table 2 ). The perinatal deaths included five stillbirths and three early neonatal deaths.
After controlling for age, parity, time since HIV diagnosis, ART duration, markers of HIV infection, and other potential confounding variables, mothers with selenium deficiency had an approximately eight-fold higher risk of preterm delivery (Table 3) and an eight-fold higher risk of delivering a neonate with a low delivery weight at term, compared with women with a normal selenium concentration (Table 4) . A low CD4 + cell count was also associated with increased risk of preterm delivery (Table 3) , and HIV disease markers and the duration of ART were associated with increased risk of term delivery of a neonate with low delivery weight (Table 4) . 
T A B L E 3 Bivariate and multivariate analyses of relationships between baseline characteristics and preterm delivery among pregnant women with HIV infection (n=113).
| DISCUSSION
In the present study, the prevalence of selenium deficiency among pregnant women with HIV infections in Lagos, Nigeria, was relatively high, and maternal selenium deficiency was significantly associated with preterm delivery and a low delivery weight among term neo- The present study did not find any association between selenium deficiency and maternal mortality. This observation is at variance with studies into HIV-related mortality carried out among nonpregnant HIV-infected participants, 18, 19 but was similar to the findings of two selenium supplementation trials 20, 21 carried out among pregnant women with HIV infections. Also, the present study did not demonstrate any association between selenium deficiency and perinatal mortality. However, this is at variance with findings from Kupka et al., 20 who reported an association between low maternal serum selenium concentrations and fetal death.
Literature on associations between selenium status and preterm delivery with a low delivery weight is scant. The significant association of preterm delivery with low maternal selenium levels found in the present study was in accordance with a study carried out in Tokyo, Japan, 22 but at variance with findings reported from Tehran, Iran. 23 However, based on a series of bivariate and multivariate analyses, the present study indicated that a low maternal serum selenium concentration may not be an independent predictor of the neonatal delivery weight in HIV-infected mothers with low CD4 + cell count, high viral load, shorter duration of ART use or lower BMI (Table 4 ).
In studies from Zaire 24 and Tokyo 22 among women who, presumably, did not have HIV, the selenium levels were lower among women who delivered neonates with a delivery weight of less than 2500 g, but no such relationship was recorded in a similar study carried out in Poland. 25 However, the present study showed a strong positive relationship between selenium deficiency and a low delivery weight in term neonates. This finding could be attributable to the presence of other influencing factors such as HIV disease markers and the duration of ART use, which were not eliminated even after multivariate analyses.
The current study was hospital-based, limiting the generalizability of the findings to the entire population of HIV-infected women in Nigeria. Moreover, it was extremely difficult to extract reliable information on the intake of selenium-rich diets from the participants, and this factor could have had some direct or indirect influence on the observed association. it is also important to highlight that the association observed in the present study does not necessarily indicate causality. However, this is the second known study among black African women that examined the possible effects of a low selenium concentration on pregnancy outcomes while carefully adjusting for confounding factors. The study provides valuable information for future robust longitudinal studies and randomized controlled trials of selenium supplementation in women with HIV who are pregnant in Nigeria, which could inform future policies on HIV care during pregnancy and on the prevention of mother-to-child transmission of the infection.
In conclusion, the present study showed a relatively high prevalence of selenium deficiency among pregnant women with HIV in
Lagos. The significant associations observed between maternal selenium deficiency and adverse pregnancy outcomes could have implications in the future management of HIV in pregnancy through the use of selenium supplementation among patient with HIV as a way of reducing these adverse outcomes. However, further research is needed to answer some of the major reservations that remain from the present study, such as the overall impacts of the various identified confounders on these relationships.
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